Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9Thoracic 1Gastrointestinal 1

Conditions

Barrett Esophagus 3Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Colorectal Neoplasms 2Thyroid Nodule 1Recurrence 1Locally Advanced Pancreatic Cancer 1Liver Cirrhosis 1Inflammatory Bowel Diseases 1Hypertension, Portal 1Gastrointestinal Neoplasms 1Fibrosis 1Esophageal Neoplasms 1Colonic Neoplasms 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 36Capecitabine 28Trastuzumab 23Paclitaxel 22Surveys and Questionnaires 20Cyclophosphamide 20Gemcitabine 18Docetaxel 18Carboplatin 15Nivolumab 14Methods 14Magnetic Resonance Spectroscopy 13Early Intervention, Educational 13Bevacizumab 13Interviews as Topic 12Blood Specimen Collection 12fludarabine 11Standard of Care 11Irinotecan 11olaparib 10durvalumab 10Specimen Handling 10Psychiatric Rehabilitation 10palbociclib 9aldesleukin 9Taxes 9Fulvestrant 9Fluorouracil 9Exercise 9Drug Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Diagnostic Imaging × Gastrointestinal × Clear all
NCT06986291 2025-05-29

CorTox

Technische Universität Dresden

Phase NA Not yet recruiting
325 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡